✉  info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Vision Care Market Research Report Information By Product Type (Contact Lens, Eyeglasses, Intraocular Lens, Contact lens solutions, and Others), By Indication (Refractive error, Glaucoma, Diabetic Retinopathy, Amblyopia, Dry Eyes, and Others), By Treatment (Surgery, Laser Therapy, and Medication), By End Users (Eye Hospitals & Clinics, Ambulatory Surgery Center, Optical Stores), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032


ID: MRFR/HC/6978-HCR | 127 Pages | Author: Rahul Gotadki| December 2024

Vision Care Market Segmentation


Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores




Vision Care Regional Outlook (USD Billion, 2018-2030)




  • North America Outlook (USD Billion, 2018-2030)




Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • US Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • CANADA Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores






  • Europe Outlook (USD Billion, 2018-2030)




Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • Germany Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • France Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • UK Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • ITALY Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • SPAIN Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • Rest Of Europe Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores






  • Asia-Pacific Outlook (USD Billion, 2018-2030)




Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • China Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • Japan Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • India Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • Australia Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores






  • Rest of the World Outlook (USD Billion, 2018-2030)




Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • Middle East Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • Africa Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores







    • Latin America Outlook (USD Billion, 2018-2030)





Vision Care Product Type Outlook (USD Billion, 2018-2030)




  • Contact Lens




  • Eyeglasses




  • Intraocular Lens




  • Contact lens solutions




  • Others)




Vision Care Indication Outlook (USD Billion, 2018-2030)




  • Refractive error




  • Glaucoma




  • Diabetic Retinopathy




  • Amblyopia




  • Dry Eyes




  • Others




Vision Care Treatment Outlook (USD Billion, 2018-2030)




  • Surgery




  • Laser Therapy




  • Medication




Vision Care End-User Outlook (USD Billion, 2018-2030)




  • Eye Hospitals & Clinics




  • Ambulatory Surgery Center




  • Optical Stores



Research Methodology on Vision Care Market


1. Research Design:


This research is undertaken to examine the Vision Care market has adopted a descriptive research design. A descriptive research design intends to describe the state of affairs as it is, with the main object of generating detailed information that explains what is being studied and understanding the nature and characteristics of the context surrounding the study. The research design adopted gives an insight into the opportunity, trends and dynamics of the global Vision Care market.


2. Target Population:


The target population of this research is large enterprises, SMEs, healthcare providers, ophthalmologists and opticians, research and consulting services providers, governing bodies, regulatory agencies, pharmaceutical companies, and venture capitalists.


3. Primary and Secondary Sources:



  • Primary research sources: Primary sources such as interviews, reviews, and site visits include executives, industry experts, directors, market analysts, OEMs, distributors, retailers, and professionals from the healthcare and pharmaceutical industry.

  • Secondary research sources: In-depth understanding and analysis of the market are obtained through secondary sources such as publications by industry associations, journals and magazines, white papers, company annual reports, SEC filings, and investor presentations.


4. Data Collection and Analysis:


Before the initiation of the data collection process, all primary research sources were identified and their source of information was thoroughly verified. Timely and accurate responses from primary research sources completely answered the objectives of the research and constituted the basis of this study. An online survey is conducted to gather data from primary research sources, using a convening analysis approach. The analysis of secondary data is performed using Porter’s Five Forces framework and market assessment methods.


The data collected from all sources are evaluated critically, and all the findings were correlated to identify the vision care market trends. The conclusions were validated by verifying facts through face-to-face interviews, telephonic conversations, and site visits.


It should also be noted that the report is a comprehensive, market-based research study of the global Vision Care market, and might, at times, be prone to numerous market-based, as well as macroeconomic, assumptions and uncertainties. As such, the report should be considered a guiding source of information which provides a thorough understanding of the global Vision Care market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL VISION CARE MARKET, BY PRODUCT TYPE

6.1. Overview

6.2. Contact Lens

6.2.1. Corrective Lens

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.2.2. Therapeutic Lens

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.2.3. Cosmetic and Lifestyle Oriented Lens

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3. Eyeglasses

6.3.1. Bifocal

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3.2. Single Vision

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3.3. Progressive

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3.4. Sunglasses

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.4. Intraocular Lens (IOL)

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.4.1. Premium

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.4.2. Traditional/Mono-focal

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.4.3. Phakic

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.5. Contact Lens Solutions

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.6. Others

7. GLOBAL VISION CARE MARKET, BY INDICATION

7.1. Overview

7.2. Refractive error

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.3. Cataract

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.4. Glaucoma

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.5. Diabetic retinopathy

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.6. Amblyopia

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.7. Dry Eyes

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.8. Others

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8. GLOBAL VISION CARE MARKET, BY TREATMENT

8.1. Overview

8.2. Surgery

8.2.1. Cataract Surgery

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.2.2. Vision correction procedures

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.2.2.1. Lasik Surgery

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.2.2.2. Implantable Contact Lens (ICL) surgery

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.2.2.3. Others

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.2.3. Cornea transplant

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.2.4. Vitrectomy

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.3. Laser therapy

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.4. Medication

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.4.1. Acetazolamide

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.4.2. Acetylcysteine

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.4.3. Gentamicin

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.4.4. Others

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.5. Others

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

9. GLOBAL VISION CARE MARKET, BY END USER

9.1. Overview

9.2. Eye Hospitals & Clinics

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

9.3. Ambulatory Surgery Center

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

9.4. Optical Stores

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

9.5. Others

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

9.6. Others

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

10. GLOBAL VISION CARE MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1.1. Overview

11.1.2. Competitive Analysis

12. COMPANY PROFILES

12.1. EssilorLuxottica

12.1.1. Company Overview

12.1.2. Product Type Overview

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Bausch Health (Bausch & Lomb Incorporated)

12.2.1. Company Overview

12.2.2. Product Type Overview

12.2.3. Financial Overview

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. The Cooper Companies, Inc (Cooper Vision)

12.3.1. Company Overview

12.3.2. Product Type Overview

12.3.3. Financial Overview

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. Novartis AG

12.4.1. Company Overview

12.4.2. Product Type Overview

12.4.3. Financial Overview

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Cadila Healthcare (Zydus Pharmaceuticals, Inc.)

12.5.1. Company Overview

12.5.2. Product Type Overview

12.5.3. Financial Overview

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Johnson & Johnson Services, Inc.

12.6.1. Company Overview

12.6.2. Product Type Overview

12.6.3. Financial Overview

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. Rayner Surgical Group Limited (Rayner Intraocular Lenses Limited)

12.7.1. Company Overview

12.7.2. Product Type Overview

12.7.3. Financial Overview

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. Menicon

12.8.1. Company Overview

12.8.2. Product Type Overview

12.8.3. Financial Overview

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.9. Carl-Zeiss-Stiftung (Carl Zeiss)

12.9.1. Company Overview

12.9.2. Product Type Overview

12.9.3. Financial Overview

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.10. Others

13. KEY STRATEGIES APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL VISION CARE MARKET SYNOPSIS, 2022-2030

TABLE 2 GLOBAL VISION CARE MARKET ESTIMATES & FORECAST, 2022-2030 (USD MILLION)

TABLE 3 GLOBAL VISION CARE MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION)

TABLE 4 GLOBAL VISION CARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)

TABLE 5 GLOBAL VISION CARE MARKET, BY TREATMENT, 2022-2030 (USD MILLION)

TABLE 6 GLOBAL VISION CARE MARKET, BY END USER, 2022-2030 (USD MILLION)

TABLE 7 GLOBAL VISION CARE MARKET, BY REGION, 2022-2030 (USD MILLION)

TABLE 8 NORTH AMERICA: VISION CARE MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION)

TABLE 9 NORTH AMERICA: VISION CARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)

TABLE 10 NORTH AMERICA: VISION CARE MARKET, BY TREATMENT, 2022-2030 (USD MILLION)

TABLE 11 NORTH AMERICA: VISION CARE MARKET, BY END USER, 2022-2030 (USD MILLION)

TABLE 12 US: VISION CARE MARKET, BY PRODUCT TYPE, 2022-2030 (USD MILLION)

TABLE 13 US: VISION CARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)

TABLE 14 US: VISION CARE MARKET, BY TREATMENT, 2022-2030 (USD MILLION)

TABLE 15 US: VISION CARE MARKET, BY END USER, 2022-2030 (USD MILLION)

TABLE 16 CANADA: VISION CARE MARKET, BY PRODUCT TYPE, 2022-2030 (US MILLION)

TABLE 17 CANADA: VISION CARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)

TABLE 18 CANADA: VISION CARE MARKET, BY TREATMENT, 2022-2030 (USD MILLION)

TABLE 19 CANADA: VISION CARE MARKET, BY END USER, 2022-2030 (USD MILLION)

TABLE 20 LATIN AMERICA: VISION CARE MARKET, BY PRODUCT TYPE, 2022-2030 (US MILLION)

TABLE 21 LATIN AMERICA: VISION CARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)

TABLE 22 LATIN AMERICA: VISION CARE MARKET, BY TREATMENT, 2022-2030 (USD MILLION)

TABLE 23 LATIN AMERICA: VISION CARE MARKET, BY END USER, 2022-2030 (USD MILLION)

TABLE 24 EUROPE: VISION CARE MARKET, BY PRODUCT TYPE, 2022-2030 (US MILLION)

TABLE 25 EUROPE: VISION CARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)

TABLE 26 EUROPE: VISION CARE MARKET, BY TREATMENT, 2022-2030 (USD MILLION)

TABLE 27 EUROPE: VISION CARE MARKET, BY END USER, 2022-2030 (USD MILLION)

TABLE 28 WESTERN EUROPE: VISION CARE MARKET, BY PRODUCT TYPE, 2022-2030 (US MILLION)

TABLE 29 WESTERN EUROPE: VISION CARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)

TABLE 30 WESTERN EUROPE: VISION CARE MARKET, BY TREATMENT, 2022-2030 (USD MILLION)

TABLE 31 WESTERN EUROPE: VISION CARE MARKET, BY END USER, 2022-2030 (USD MILLION)

TABLE 32 EASTERN EUROPE: VISION CARE MARKET, BY PRODUCT TYPE, 2022-2030 (US MILLION)

TABLE 33 EASTERN EUROPE: VISION CARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)

TABLE 34 EASTERN EUROPE: VISION CARE MARKET, BY TREATMENT, 2022-2030 (USD MILLION

TABLE 35 EASTERN EUROPE: VISION CARE MARKET, BY END USER, 2022-2030 (USD MILLION)

TABLE 36 ASIA-PACIFIC: VISION CARE MARKET, BY PRODUCT TYPE, 2022-2030 (US MILLION)

TABLE 37 ASIA-PACIFIC: VISION CARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)

TABLE 38 ASIA-PACIFIC: VISION CARE MARKET, BY TREATMENT, 2022-2030 (USD MILLION)

TABLE 39 ASIA-PACIFIC: VISION CARE MARKET, BY END USER, 2022-2030 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: VISION CARE MARKET, BY PRODUCT TYPE, 2022-2030 (US MILLION)

TABLE 41 MIDDLE EAST & AFRICA: VISION CARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: VISION CARE MARKET, BY TREATMENT, 2022-2030 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: VISION CARE MARKET, BY END USER, 2022-2030 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL VISION CARE MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL VISION CARE MARKET

FIGURE 4 GLOBAL VISION CARE MARKET SHARE, BY PRODUCT TYPE, 2020 (%)

FIGURE 5 GLOBAL VISION CARE MARKET SHARE, BY INDICATION, 2020 (%)

FIGURE 6 GLOBAL VISION CARE MARKET SHARE, BY TREATMENT, 2020 (%)

FIGURE 7 GLOBAL VISION CARE MARKET SHARE, BY END USER, 2020 (%)

FIGURE 8 GLOBAL VISION CARE MARKET SHARE, BY REGION, 2020 (%)

FIGURE 7 AMERICAS: VISION CARE MARKET SHARE BY REGION, 2020 (%)

FIGURE 9 NORTH AMERICA: VISION CARE MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 EUROPE: VISION CARE MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 WESTERN EUROPE: VISION CARE MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 ASIA-PACIFIC: VISION CARE MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 MIDDLE EAST & AFRICA: VISION CARE MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 GLOBAL VISION CARE MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 ESSILORLUXOTTICA.: KEY FINANCIALS

FIGURE 16 ESSILORLUXOTTICA.: SEGMENTAL REVENUE

FIGURE 17 ESSILORLUXOTTICA.: REGIONAL REVENUE

FIGURE 18 BAUSCH HEALTH (BAUSCH & LOMB INCORPORATED): KEY FINANCIALS

FIGURE 19 BAUSCH HEALTH (BAUSCH & LOMB INCORPORATED): SEGMENTAL REVENUE

FIGURE 20 BAUSCH HEALTH (BAUSCH & LOMB INCORPORATED): REGIONAL REVENUE

FIGURE 21 THE COOPER COMPANIES, INC (COOPERVISION): KEY FINANCIALS

FIGURE 22 THE COOPER COMPANIES, INC (COOPERVISION): SEGMENTAL REVENUE

FIGURE 23 THE COOPER COMPANIES, INC (CooperVision): REGIONAL REVENUE

FIGURE 24 NOVARTIS AG.: KEY FINANCIALS

FIGURE 25 NOVARTIS AG.: SEGMENTAL REVENUE

FIGURE 26 NOVARTIS AG.: REGIONAL REVENUE

FIGURE 27 CADILA HEALTHCARE (ZYDUS PHARMACEUTICALS, INC.): KEY FINANCIALS

FIGURE 28 CADILA HEALTHCARE (ZYDUS PHARMACEUTICALS, INC.): SEGMENTAL REVENUE

FIGURE 29 CADILA HEALTHCARE (ZYDUS PHARMACEUTICALS, INC.): REGIONAL REVENUE

FIGURE 30 JOHNSON & JOHNSON SERVICES, INC.: KEY FINANCIALS

FIGURE 31 JOHNSON & JOHNSON SERVICES, INC.: SEGMENTAL REVENUE

FIGURE 32 JOHNSON & JOHNSON SERVICES, INC.: REGIONAL REVENUE

FIGURE 33 RAYNER SURGICAL GROUP LIMITED (RAYNER INTRAOCULAR LENSES LIMITED): KEY FINANCIALS

FIGURE 34 RAYNER SURGICAL GROUP LIMITED (RAYNER INTRAOCULAR LENSES LIMITED): SEGMENTAL REVENUE

FIGURE 35 RAYNER SURGICAL GROUP LIMITED (RAYNER INTRAOCULAR LENSES LIMITED): REGIONAL REVENUE

FIGURE 36 MENICON: KEY FINANCIALS

FIGURE 37 MENICON: SEGMENTAL REVENUE

FIGURE 38 MENICON: REGIONAL REVENUE

FIGURE 39 CARL-ZEISS-STIFTUNG (CARL ZEISS): KEY FINANCIALS

FIGURE 40 CARL-ZEISS-STIFTUNG (CARL ZEISS): SEGMENTAL REVENUE

FIGURE 41 CARL-ZEISS-STIFTUNG (CARL ZEISS): REGIONAL REVENUE

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Related Reports
report-img
AI Clinical Care Market Research Report — Global Forecast till 2032
report-img
Corneal Surgery Devices Market Research Report - Global Forecast till 2032
report-img
Healthcare Creditor Insurance Market Research Report - Forecast till 2032
report-img
AI Robots Market Research Report - Global Forecast to 2032
Press Release
Category icon
Vision Care Market: The Rising Prevalence of Visual Inaccuracies and Eye Disorders are Projected ...
Logo
Dmca Cloudflare ssl
Paypal footer Ssl
Services Industry Expertise Consulting Services Articles How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners
Amex Mastercard1
Razerpay
Hdfcbank
Visa
✉  info@marketresearchfuture.com
📞  +1 (855) 661-4441(US)
📞  +44 1720 412 167(UK)

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)